Assessment of Normal distribution Across Treatment Groups
Shapiro-Wilk test for HDL, LDL, and Triglycerides
Lipid Marker	Treatment Cohort	Sample Size (n)	W-Statistic	p-value
HDL	IR	22	0.883	0.014
HDL	Medical Therapy	246	0.927	< 0.001
HDL	TNK/TPA	80	0.958	0.011
LDL	IR	22	0.974	0.799
LDL	Medical Therapy	246	0.890	< 0.001
LDL	TNK/TPA	80	0.989	0.748
Triglycerides	IR	21	0.733	< 0.001
Triglycerides	Medical Therapy	246	0.726	< 0.001
Triglycerides	TNK/TPA	80	0.786	< 0.001